Suppr超能文献

相似文献

1
Control of B lymphocyte development and functions by the mTOR signaling pathways.
Cytokine Growth Factor Rev. 2017 Jun;35:47-62. doi: 10.1016/j.cytogfr.2017.04.005. Epub 2017 May 22.
2
The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.
Nutrients. 2017 Oct 27;9(11):1176. doi: 10.3390/nu9111176.
3
Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin.
Curr Cancer Drug Targets. 2016;16(4):288-304. doi: 10.2174/1568009616666151113120830.
4
RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.
Anticancer Drugs. 2016 Jul;27(6):475-87. doi: 10.1097/CAD.0000000000000354.
5
Dynamic modeling of signal transduction by mTOR complexes in cancer.
J Theor Biol. 2019 Dec 21;483:109992. doi: 10.1016/j.jtbi.2019.109992. Epub 2019 Sep 4.
6
Dynamic modelling of the PI3K/MTOR signalling network uncovers biphasic dependence of mTORC1 activity on the mTORC2 subunit SIN1.
PLoS Comput Biol. 2021 Sep 16;17(9):e1008513. doi: 10.1371/journal.pcbi.1008513. eCollection 2021 Sep.
7
Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.
Adv Biol Regul. 2017 May;64:39-48. doi: 10.1016/j.jbior.2016.12.001. Epub 2017 Jan 4.
8
mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation.
Nat Commun. 2016 Oct 27;7:13226. doi: 10.1038/ncomms13226.
9
Structural mechanisms of the mTOR pathway.
Curr Opin Struct Biol. 2023 Oct;82:102663. doi: 10.1016/j.sbi.2023.102663. Epub 2023 Aug 10.
10
Mechanistic target of rapamycin: integrating growth factor and nutrient signaling in the collecting duct.
Am J Physiol Renal Physiol. 2018 Sep 1;315(3):F413-F416. doi: 10.1152/ajprenal.00170.2018. Epub 2018 May 30.

引用本文的文献

2
mTOR promotes the formation and growth of tertiary lymphoid tissues in the kidney.
Front Immunol. 2025 May 27;16:1527817. doi: 10.3389/fimmu.2025.1527817. eCollection 2025.
3
B Cell Lineage in the Human Endometrium: Physiological and Pathological Implications.
Cells. 2025 Apr 29;14(9):648. doi: 10.3390/cells14090648.
4
Microbiota-Derived Inosine Suppresses Systemic Autoimmunity via Restriction of B Cell Differentiation and Migration.
Adv Sci (Weinh). 2025 May;12(20):e2409837. doi: 10.1002/advs.202409837. Epub 2025 Apr 28.
5
Diffusion-based generation of gene regulatory networks from scRNA-seq data with DigNet.
Genome Res. 2025 Feb 14;35(2):340-354. doi: 10.1101/gr.279551.124.
6
Microarray analysis of signalling interactions between inflammation and angiogenesis in subchondral bone in temporomandibular joint osteoarthritis.
Biomater Transl. 2024 Jun 28;5(2):175-184. doi: 10.12336/biomatertransl.2024.02.007. eCollection 2024.
8
Regulation of Foxo1 expression is critical for central B cell tolerance and allelic exclusion.
Cell Rep. 2024 Jun 25;43(6):114283. doi: 10.1016/j.celrep.2024.114283. Epub 2024 May 25.
9
B cell receptor signaling and associated pathways in the pathogenesis of chronic lymphocytic leukemia.
Front Oncol. 2024 Feb 26;14:1339620. doi: 10.3389/fonc.2024.1339620. eCollection 2024.
10
Prednisolone and rapamycin reduce the plasma cell gene signature and may improve AAV gene therapy in cynomolgus macaques.
Gene Ther. 2024 Mar;31(3-4):128-143. doi: 10.1038/s41434-023-00423-z. Epub 2023 Oct 13.

本文引用的文献

1
mTOR Signaling in Growth, Metabolism, and Disease.
Cell. 2017 Mar 9;168(6):960-976. doi: 10.1016/j.cell.2017.02.004.
2
Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.
Adv Biol Regul. 2017 May;64:39-48. doi: 10.1016/j.jbior.2016.12.001. Epub 2017 Jan 4.
3
m-TOR inhibitors and their potential role in haematological malignancies.
Br J Haematol. 2017 Jun;177(5):684-702. doi: 10.1111/bjh.14529. Epub 2017 Feb 1.
4
Modulation of mTOR signaling as a strategy for the treatment of Pompe disease.
EMBO Mol Med. 2017 Mar;9(3):353-370. doi: 10.15252/emmm.201606547.
6
Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years.
Curr Rheumatol Rep. 2016 Dec;18(12):73. doi: 10.1007/s11926-016-0622-8.
7
8
mTOR has distinct functions in generating versus sustaining humoral immunity.
J Clin Invest. 2016 Nov 1;126(11):4250-4261. doi: 10.1172/JCI86504. Epub 2016 Oct 17.
9
mTORC1 and mTORC2 in cancer and the tumor microenvironment.
Oncogene. 2017 Apr 20;36(16):2191-2201. doi: 10.1038/onc.2016.363. Epub 2016 Oct 17.
10
Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer.
Recent Results Cancer Res. 2016;207:39-72. doi: 10.1007/978-3-319-42118-6_3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验